653 Improving Epidermal Function Normalizes Circulating Levels of Key Pro-Inflammatory Cytokines in Aged Humans

L. Ye,T. Mauro,E. Dang,G. Wang,L. Hu,C. Yu,S. Jeong,Z. Li,C. Lv,L. He,K. Feingold,P. Elias,M. Man
DOI: https://doi.org/10.1016/j.jid.2018.03.662
IF: 7.59
2018-01-01
Journal of Investigative Dermatology
Abstract:Elevated circulating levels of three pro-inflammatory cytokines (IL-1β IL-6 and TNFα) are linked to the development of multiple, age-associated chronic disorders in aged humans (arthrosclerosis, diabetes, and Alzheimers disease. While regimens that reduce levels of circulating cytokines are not yet available, our recent studies in aged mice demonstrate that 1) age-associated epidermal dysfunction stimulates cutaneous pro-inflammatory cytokine production, accounting elevations in circulating cytokine levels, independent of liver or T-cell contributions; and 2) approaches that improve epidermal function reduce not only cutaneous, but also circulating cytokine levels. We determined here whether improvements in epidermal function reduce circulating levels of pro-inflammatory cytokines in 33 humans, treated twice-daily with a topical formulation previously shown to improve epidermal function in humans. Controls included 30 untreated, aged humans. Eleven additional volunteers served as young controls. Both epidermal functions and plasma levels of IL-1β, IL-6 and TNFα were measured at baseline and after 30 days of treatment. Aged humans displayed significantly higher basal levels of all 3 cytokines (p correcting age-associated abnormalities in cutaneous function alone can mitigate age-associated systemic inflammation, perhaps attenuating the subsequent development of inflammation-associated chronic disorders.
What problem does this paper attempt to address?